Biopharma AI
By
How Will Lantern Pharma’s PredictBBB.ai Advance with 94% Accuracy Revolutionize CNS Drug Development?
Key Highlights Breakthrough AI Methodology Sets New Industry BenchmarkLantern’s proprietary ensemble of machine learning algorithms—including logistic regression, random…
Can Phare Bio’s AI-Driven Antibiotic Discovery Win Herald a New Era in Combating Antimicrobial Resistance?
Key Highlights Harnessing Generative AI to Revolutionize Antibiotic DiscoveryPhare Bio leverages cutting-edge AI to drastically shorten the traditionally…
Will Sanofi’s AI Ethics Revolution Trigger a $100 Billion Shift in Biopharma and Medtech? How the Company’s Transparency Drive is Reshaping Global Healthcare
Key Highlights: AI Ethics at Scale: Sanofi Sets Global Leadership StandardSanofi’s establishment of a dedicated AI Ethical Review…
Can IGC Pharma’s New AI Models Change Alzheimer’s Diagnosis and Drug Discovery for Millions?
New tools unveiled at AAIC 2025 aim to detect Alzheimer’s earlier and faster, even in low-resource settings Key…
How Did Sanofi’s 2025 Deals Shape Its Strategy and What Do They Mean for the Future?
In 2025, Sanofi pursued a series of strategic collaborations, acquisitions, and licensing agreements aimed at strengthening its core…
What Lessons from Sanofi’s 2025 Execution Signal Its Future in Oncology, Immunology, and Vaccines?
Sanofi concluded 2025 with a combination of solid portfolio performance, strategic execution, and continued innovation across its pharmaceuticals,…
